| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | | Total Revenue | 21,648,000 | 33,926,000 | 20,458,000 | 898,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 33,926,000 | 20,458,000 | 898,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,885,000 | 25,263,000 | 23,619,000 | 24,181,000 | | Non Recurring | 371,000 | 343,000 | 362,000 |
-
| | Others | 3,089,000 | 4,401,000 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,652,000) | 3,919,000 | (3,523,000) | (23,283,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,303,000 | 3,919,000 | (3,523,000) | (23,283,000) | | Interest Expense | 2,510,000 | 2,600,000 | 2,845,000 | 4,902,000 | | Income Before Tax | (207,000) | 1,319,000 | (6,368,000) | (28,185,000) | | Income Tax Expense | (192,000) | (526,000) | (1,235,000) | (3,480,000) | | Minority Interest |
-
|
-
|
-
| 237,000 | | | | Net Income From Continuing Ops | (15,000) | 1,845,000 | (5,133,000) | (24,468,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,212,000 | 1,845,000 | (5,133,000) | (24,468,000) | | Preferred Stock And Other Adjustments |
-
| (23,000) | 780,000 |
-
| | | Net Income Applicable To Common Shares | ($840,000) | $1,822,000 | ($4,353,000) | ($24,468,000) |
|
0.16% Nasdaq 
Income Statement
